News About: Pharm. Industry
License agreement for development and sales of new anti-ulcerant
Choong-wae Pharm concluded a license agreement with Mitsubishi Tanabe Pharma on April 26, granting Choong-wae exclusive rights in Korea for the development and sale of S-Tenatoprazole-Na (STU-Na), a new drug currently...
Korean pharmaceutical firms urged to adopt U.S. and E.U. risk management practices
Local pharmaceutical companies need to implement safety and other best practices to comply with any possible litigation and regulatory risks in U.S. and European markets, according to a foreign executive for Chubb Gro...
Hyundai Pharm seeks global expansion
Influenced by more aggravating pharmaceutical environments, Hyundai Pharm is ramping up its overseas expansion drive, with the aim of becoming a leading pharmaceutical firm in global arena.
The company is expanding...
Korea Eundan advocates quality differentiation of vitamin C
Korea Eundan is emphasising quality as the crucial point of differentiation between the vitamin C it produces in the green hills of Scotland - now known as Quali-C.
The company said on April 23 that it signed an ex...
Celltrion to boost biosimilar business
Celltrion Inc., the largest biopharmaceutical contract manufacturer in Asia, said in its regulatory filing on April 22 that the company has signed a contract with Singapore's state-run Temasek Holdings to receive $200...
Singulair alleviates recurrent wheezing with RSV bronchiolitis
Singulair (montelukast), a leukotriene receptor antagonist, can help prevent recurrent wheezing episodes after respiratory syncytial virus (RSV) bronchiolitis, according to Korean scientists.
From earlier work, the...
Mundiphara releases slow release iron tablets
Mundipharma says it has launched a novel slow release form of an iron supplement “Hemocontin”, to commemorate its 25-year launching in Korea.
The company said Hyundai Pharm will responsible for the co-promotion of ...
Leading firms’ generic sales growth are stable
Domestic leading drugmakers have enjoyed strong returns, thanks much to increasing market demand. Industry sources expect sales will rise consistently, and Korean drug firms will continue to make a soft landing into t...
KFDA set to help pharmaceutical export
The Korea Food and Drug Administration said that from next month, the health watchdog will implement a “mocking GMP (good manufacturing practice) inspection program” that will exclusively provide necessary services to...
CJ to collaborate with Seoul National University Hospital
CJ Cheil Jedang announced on April 19 that it has entered into a collaborative agreement with Seoul National University Hospital, led by Prof. Kim Hyo-soo and Prof. Kang Hyun-jae.
The goal of the collaboration is t...
